Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E3.07 EPS (ttm)0.51 Insider Own14.07% Shs Outstand112.59M Perf Week22.05%
Market Cap174.88M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float96.95M Perf Month-13.17%
Income52.20M PEG- EPS next Q- Inst Own0.10% Short Float0.12% Perf Quarter-20.92%
Sales414.10M P/S0.42 EPS this Y- Inst Trans-29.23% Short Ratio1.44 Perf Half Y-44.64%
Book/sh0.35 P/B4.43 EPS next Y- ROA10.77% Short Interest0.11M Perf Year-42.70%
Cash/sh0.16 P/C9.96 EPS next 5Y- ROE350.21% 52W Range0.50 - 4.95 Perf YTD-61.92%
Dividend Est.- P/FCF8.56 EPS past 5Y- ROI20.07% 52W High-68.69% Beta0.10
Dividend TTM- Quick Ratio0.99 Sales past 5Y- Gross Margin55.04% 52W Low210.00% ATR (14)0.27
Dividend Ex-Date- Current Ratio1.47 EPS Y/Y TTM164.95% Oper. Margin8.15% RSI (14)52.58 Volatility36.56% 26.73%
Employees- Debt/Eq7.36 Sales Y/Y TTM-4.80% Profit Margin12.61% Recom3.00 Target Price4.50
Option/ShortNo / Yes LT Debt/Eq5.60 EPS Q/Q-63.68% Payout- Rel Volume0.52 Prev Close1.62
Sales Surprise6.88% EPS Surprise0.00% Sales Q/Q7.25% Earnings- Avg Volume79.10K Price1.55
SMA2025.72% SMA50-8.51% SMA200-36.16% Trades Volume19,859 Change-4.62%
Nov-15-24 06:15PM
Oct-10-24 05:26PM
Sep-18-24 08:10AM
Sep-03-24 09:10AM
Jul-01-24 02:18PM
08:31AM Loading…
Jun-28-24 08:31AM
May-20-24 04:05PM
May-14-24 04:10PM
May-01-24 04:10PM
Mar-04-24 08:00AM
Feb-05-24 08:50AM
Jan-16-24 08:50AM
Dec-26-23 05:40PM
Dec-21-23 06:45PM
Nov-29-23 07:54PM
08:30AM Loading…
Nov-22-23 08:30AM
Nov-14-23 05:25PM
Nov-10-23 11:37AM
Oct-30-23 08:30AM
Oct-23-23 05:01PM
Oct-16-23 08:31AM
Oct-02-23 08:00AM
Sep-15-23 08:20AM
Sep-07-23 08:30AM
Sep-05-23 08:25AM
Aug-31-23 06:35PM
Aug-16-23 08:31AM
Jun-05-23 07:45PM
May-12-23 05:30PM
May-01-23 08:17AM
04:36PM Loading…
Feb-13-23 04:36PM
Jan-19-23 04:32PM
Jan-03-23 04:13PM
Dec-29-22 08:00AM
Dec-22-22 04:02PM
Nov-14-22 05:32PM
Nov-08-22 03:36PM
Oct-11-22 08:00AM
Oct-05-22 10:15AM
Aug-30-22 06:40AM
Aug-15-22 06:25AM
Jun-26-22 08:33AM
Jun-02-22 08:14AM
May-22-22 10:31AM
May-17-22 04:44PM
Apr-29-22 09:12PM
Apr-22-22 08:20AM
Mar-08-22 04:38AM
Feb-08-22 01:38PM
Feb-02-22 08:31AM
Jan-28-22 09:26AM
Jan-12-22 08:31AM
Nov-29-21 07:58AM
Nov-19-21 08:41AM
Procaps Group SA is an international healthcare and pharmaceutical company. The firm is engaged in the developing of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It operates through the following segments: NextGel, Procaps Colombia, CAN, CASAND, and Diabetrics. The NextGel segment is involved in the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in USA, Brazil, and Colombia. The Procaps Colombia segment is focused on the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in Colombia. The CAN segment deals with the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in Northern Central America: Salvador, Guatemala, Nicaragua, and Honduras. The CASAND segment offers pharmaceutical products in Southern Central America that include Panama and Costa Rica, and the North Andes District that include Ecuador, Peru, and Bolivia. The Diabetrics segment consists of the diabetes solutions and chronic disease management tool. The company was founded by Ruben Minski in 1977 and is headquartered in Luxembourg.